Clinical Trials
2 trialsNCT06876714 2026-06-02
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT03505736 2026-01-29
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer
Wake Forest University Health Sciences
Completed